Emcure Pharmaceuticals consolidated net profit rises 33.73% in the September 2026 quarter
(03 Nov 2026)

Back
Net profit of Emcure Pharmaceuticals rose 33.73% to Rs 325.57 crore in the quarter ended September 2026 as against Rs 243.46 crore during the previous quarter ended September 2025. Sales rose 24.26% to Rs 2820.47 crore in the quarter ended September 2026 as against Rs 2269.82 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales2820.472269.82 24
OPM %20.8420.95 -
PBDT555.52446.06 25
PBT445.85341.42 31
NP325.57243.46 34
BSE Delayed data sourced at 5 mins : www.bseindia.com | NSE Delayed data sourced at 15 mins : www.nseindia.com

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew